| Authors: |
Shah MH; Ohio State University College of Medicine, Columbus, OH, 43210, USA., Lorigan P; University of Manchester/Christie NHS Foundation Trust, Manchester, M20 4BX, UK., O'Brien ME; Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, UK., Fossella FV; Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Moore KN; University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Bhatia S; Department of Medicine, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA., Kirby M; ImmunoGen, Inc., Waltham, MA, 02451, USA., Woll PJ; Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Whitham Road, Sheffield, S10 2SJ, UK. p.j.woll@sheffield.ac.uk. |
